A 60-year-old man presented with fatigue, malaise and shortness of breath. A hematology workup revealed hematocrit 36%, hemoglobin 12 g/dl, and platelets 90,000/μl.


Acute Myeloid Leukemia Acute Myeloblastic Leukemia Hematologic Neoplasm Mature Granulocyte Myeloid Marker 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Arber DA, Brunning RD, Orazi A, et al. Acute myeloid leukaemia, not otherwise specified. In Swerdlow SH, Campo E, Harris NL, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed., Lyon, France, IARC Press, 2008, 131–132.Google Scholar
  2. 2.
    Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620–624.PubMedGoogle Scholar
  3. 3.
    Second MIC Cooperative Study Group. Morphologic immunologic and cytogenetic (MIC) working classification of the acute myeloid leukemias. Br J Haematol 1988;68:487–494.Google Scholar
  4. 4.
    Hans CP, Finn WG, Singleton TP, et al. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia. Am J Clin Pathol 2002;117:301–305.CrossRefPubMedGoogle Scholar
  5. 5.
    Kita K, Miwa H, Nakase K, et al. Clinical importance of CD7 expression in acute myelocytic leukemia. Blood 1993;81:2399–2405.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Personalised recommendations